Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenxiang Suhe Pill for posterior circulation ischemic vertigo
ChiCTR2300077782Phase 4Completed
- Sponsor
- Tongde Hospital of Zhejiang Province
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of suhexiang pill in Vertebrobasilar Atherosclerosis and vertigo (3 arms), sponsored by Tongde Hospital of Zhejiang Province. Primary endpoint: Transcranial Doppler. Started Jan 2021; status: completed.
02
Drugs
suhexiang pill
03
Conditions
Vertebrobasilar Atherosclerosisvertigo
Beyond the preview
Go deeper on ChiCTR2300077782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077782.